Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images
- 28 July 2016
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica
- Vol. 58 (4) , 481-488
Abstract
Background: Further research is required for evaluating the use of ADC histogram analysis in more advanced stages of cervical cancer treated with definitive chemoradiotherapy (CRT). Purpose: To investigate the utility of apparent diffusion coefficient (ADC) histogram derived from diffusion-weighted magnetic resonance images in cervical cancer patients treated with definitive CRT. Material and Methods: The clinical and radiological data of 50 patients with histologically proven cervical squamous cell carcinoma treated with definitive CRT were retrospectively analyzed. The impact of clinicopathological factors and ADC histogram parameters on prognostic factors and treatment outcomes was assessed. Results: The mean and median ADC values for the cohort were 1.043 ± 0.135 × 10−3 mm2/s and 1.018 × 10−3 mm2/s (range, 0.787–1.443 × 10−3 mm2/s). The mean ADC was significantly lower for patients with advanced stage (≥IIB) or lymph node metastasis compared with patients with stage <IIB or no lymph node metastasis. The mean ADC, 75th percentile ADC (ADC75), 90th percentile ADC (ADC90), and 95th percentile ADC (ADC95) were significantly lower in patients with tumor recurrence compared with patients without recurrence. In multivariate analysis, tumor size, ADC75 and ADC95 were independent prognostic factors for both overall survival and disease-free survival. Conclusion: ADC histogram parameters could be markers for disease recurrence and for predicting survival outcomes. ADC75, ADC90, and ADC95 of the primary tumor were significant predictors of disease recurrence in cervical cancer patients treated with definitive CRT.Keywords
This publication has 25 references indexed in Scilit:
- The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment ADCmean of primary tumor as a predictor of prognosis with cervical cancerCancer Medicine, 2013
- Pre-Treatment Diffusion-Weighted MR Imaging for Predicting Tumor Recurrence in Uterine Cervical Cancer Treated with Concurrent Chemoradiation: Value of Histogram Analysis of Apparent Diffusion CoefficientsKorean Journal of Radiology, 2013
- Diffusion weighted imaging of female pelvic cancers: Concepts and clinical applicationsEuropean Journal of Radiology, 2011
- The influence of the b‐value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancerJournal of Magnetic Resonance Imaging, 2010
- Predicting and monitoring cancer treatment response with diffusion‐weighted MRIJournal of Magnetic Resonance Imaging, 2010
- The utility of diffusion-weighted MR imaging in cervical cancerEuropean Journal of Radiology, 2010
- Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk dosesJournal of Experimental & Clinical Cancer Research, 2009
- Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective studyInternational Journal of Gynecological Cancer, 2007
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapyGynecologic Oncology, 2005